These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 32926322)

  • 21. Xiaoyaosan exerts antidepressant-like effects by regulating the functions of astrocytes and EAATs in the prefrontal cortex of mice.
    Liu Y; Ding XF; Wang XX; Zou XJ; Li XJ; Liu YY; Li J; Qian XY; Chen JX
    BMC Complement Altern Med; 2019 Aug; 19(1):215. PubMed ID: 31412844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacology of excitatory amino acid transporters (EAATs and VGLUTs)].
    Shigeri Y; Shimamoto K
    Nihon Yakurigaku Zasshi; 2003 Sep; 122(3):253-64. PubMed ID: 12939543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective properties of the excitatory amino acid carrier 1 (EAAC1).
    Aoyama K; Nakaki T
    Amino Acids; 2013 Jul; 45(1):133-42. PubMed ID: 23462929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamatergic systems in neuropathic pain and emerging non-opioid therapies.
    Temmermand R; Barrett JE; Fontana ACK
    Pharmacol Res; 2022 Nov; 185():106492. PubMed ID: 36228868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current approaches to enhance glutamate transporter function and expression.
    Fontana AC
    J Neurochem; 2015 Sep; 134(6):982-1007. PubMed ID: 26096891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy.
    Proper EA; Hoogland G; Kappen SM; Jansen GH; Rensen MG; Schrama LH; van Veelen CW; van Rijen PC; van Nieuwenhuizen O; Gispen WH; de Graan PN
    Brain; 2002 Jan; 125(Pt 1):32-43. PubMed ID: 11834591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal reduction of neuronal glutamate transporters in human neocortical epilepsy.
    Rakhade SN; Loeb JA
    Epilepsia; 2008 Feb; 49(2):226-36. PubMed ID: 17868051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glial Excitatory Amino Acid Transporters and Glucose Incorporation.
    Gutiérrez Aguilar GF; Alquisiras-Burgos I; Espinoza-Rojo M; Aguilera P
    Adv Neurobiol; 2017; 16():269-282. PubMed ID: 28828615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamate-based therapeutic approaches: targeting the glutamate transport system.
    Dunlop J
    Curr Opin Pharmacol; 2006 Feb; 6(1):103-7. PubMed ID: 16368269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamate transporter blockers for elucidation of the function of excitatory neurotransmission systems.
    Shimamoto K
    Chem Rec; 2008; 8(3):182-99. PubMed ID: 18563834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excitatory amino acid transporters: roles in glutamatergic neurotransmission.
    Divito CB; Underhill SM
    Neurochem Int; 2014 Jul; 73():172-80. PubMed ID: 24418112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.
    Takahashi K; Foster JB; Lin CL
    Cell Mol Life Sci; 2015 Sep; 72(18):3489-506. PubMed ID: 26033496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical and functional interaction of NCX1 and EAAC1 transporters leading to glutamate-enhanced ATP production in brain mitochondria.
    Magi S; Lariccia V; Castaldo P; Arcangeli S; Nasti AA; Giordano A; Amoroso S
    PLoS One; 2012; 7(3):e34015. PubMed ID: 22479505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute regulation of sodium-dependent glutamate transporters: a focus on constitutive and regulated trafficking.
    Robinson MB
    Handb Exp Pharmacol; 2006; (175):251-75. PubMed ID: 16722240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and functional analysis of Na(+)-dependent glutamate transporters from zebrafish brain.
    Rico EP; de Oliveira DL; Rosemberg DB; Mussulini BH; Bonan CD; Dias RD; Wofchuk S; Souza DO; Bogo MR
    Brain Res Bull; 2010 Mar; 81(4-5):517-23. PubMed ID: 19941938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of excitatory amino acid transporters in cerebral ischemia.
    Chao XD; Fei F; Fei Z
    Neurochem Res; 2010 Aug; 35(8):1224-30. PubMed ID: 20440555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.
    Sheldon AL; Robinson MB
    Neurochem Int; 2007; 51(6-7):333-55. PubMed ID: 17517448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal high-affinity sodium-dependent glutamate transporters (EAATs): targets for the development of novel therapeutics against neurodegenerative diseases.
    Campiani G; Fattorusso C; De Angelis M; Catalanotti B; Butini S; Fattorusso R; Fiorini I; Nacci V; Novellino E
    Curr Pharm Des; 2003; 9(8):599-625. PubMed ID: 12570795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caffeine alters glutamate-aspartate transporter function and expression in rat retina.
    de Freitas AP; Ferreira DD; Fernandes A; Martins RS; Borges-Martins VP; Sathler MF; Dos-Santos-Pereira M; Paes-de-Carvalho R; Giestal-de-Araujo E; de Melo Reis RA; Kubrusly RC
    Neuroscience; 2016 Nov; 337():285-294. PubMed ID: 27663541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preconditioning with cortical spreading depression decreases intraischemic cerebral glutamate levels and down-regulates excitatory amino acid transporters EAAT1 and EAAT2 from rat cerebal cortex plasma membranes.
    Douen AG; Akiyama K; Hogan MJ; Wang F; Dong L; Chow AK; Hakim A
    J Neurochem; 2000 Aug; 75(2):812-8. PubMed ID: 10899959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.